Cargando…
Expansion of FasL-Expressing CD5(+) B Cells in Type 1 Diabetes Patients
Fas ligand drives insulitis in the non-obese diabetic mouse model of type 1 diabetes (T1D) and negatively regulates IL-10-producing (IL-10(pos)) CD5(+) B cells in pancreata. Relevance of these phenomena to the human disease is poorly understood. Here, using splenocytes from T1D, autoantibody (Ab(+))...
Autores principales: | Saxena, Ankit, Yagita, Hideo, Donner, Thomas W., Hamad, Abdel Rahim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383713/ https://www.ncbi.nlm.nih.gov/pubmed/28439273 http://dx.doi.org/10.3389/fimmu.2017.00402 |
Ejemplares similares
-
Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
por: Flores-Mendoza, Giovanna, et al.
Publicado: (2021) -
Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
por: Krzyzowska, Malgorzata, et al.
Publicado: (2021) -
Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance
por: Yamada, Akiko, et al.
Publicado: (2017) -
FasL Is Required for Osseous Healing in Extraction Sockets in Mice
por: Apaza Alccayhuaman, Karol Alí, et al.
Publicado: (2021) -
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)